Journey Medical Corp reports results for the quarter ended December 31 - Earnings Summary

• Journey Medical Corp DERM.OQ reported a quarterly adjusted loss of 15 cents​​ per share for the quarter ended December 31, lower than the same quarter last year, when the company reported EPS of -12 cents. The mean expectation of four analysts for the quarter was for a loss of 35 cents per share. Wall Street expected results to range from -83 cents to -15 cents per share.

• Revenue fell 10.7% to $13.62 million from a year ago; analysts expected $14.21 million.

• Journey Medical Corp's reported EPS for the quarter was 8 cents​.

• The company reported quarterly net income of $1.52 million.

• Journey Medical Corp shares had risen by 65.7% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts was unchanged in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the pharmaceuticals peer group is also "buy"

Wall Street's median 12-month price target for Journey Medical Corp is $10.00

This summary was machine generated from LSEG data March 26 at 09:01 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)